Cargando…

Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets

Genomic analyses promise to improve tumor characterization in order to optimize personalized treatment for patients with hepatocellular carcinoma (HCC). Exome sequencing analysis of 243 liver tumors revealed mutational signatures associated with specific risk factors, mainly combined alcohol/tobacco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schulze, Kornelius, Imbeaud, Sandrine, Letouzé, Eric, Alexandrov, Ludmil B, Calderaro, Julien, Rebouissou, Sandra, Couchy, Gabrielle, Meiller, Clément, Shinde, Jayendra, Soysouvanh, Frederic, Calatayud, Anna-Line, Pinyol, Roser, Pelletier, Laura, Balabaud, Charles, Laurent, Alexis, Blanc, Jean-Frederic, Mazzaferro, Vincenzo, Calvo, Fabien, Villanueva, Augusto, Nault, Jean-Charles, Bioulac-Sage, Paulette, Stratton, Michael R, Llovet, Josep M, Zucman-Rossi, Jessica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587544/ https://www.ncbi.nlm.nih.gov/pubmed/25822088 http://dx.doi.org/10.1038/ng.3252

Ejemplares similares

Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress
por: Bayard, Quentin, et al.
Publicado: (2018)

Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis
por: Letouzé, Eric, et al.
Publicado: (2017)

Corrigendum: High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
por: Charles Nault, Jean, et al.
Publicado: (2013)

High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
por: Nault, Jean Charles, et al.
Publicado: (2013)

Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas
por: Pilati, Camilla, et al.
Publicado: (2011)

Double Heterozygous Germline HNF1A Mutations in a Patient With Liver Adenomatosis
por: Jeannot, Emmanuelle, et al.
Publicado: (2012)

Integration of tumour and viral genomic characterisations in HBV-related hepatocellular carcinomas
por: Amaddeo, Giuliana, et al.
Publicado: (2015)

Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma
por: Péneau, Camille, et al.
Publicado: (2022)

Hepatocellular adenoma: what is new in 2008
por: Bioulac-Sage, Paulette, et al.
Publicado: (2008)

HNF1α inhibition triggers epithelial-mesenchymal transition in human liver cancer cell lines
por: Pelletier, Laura, et al.
Publicado: (2011)

Hypervascular nodule in a fibrotic liver overloaded with iron: identification of a premalignant area with preserved liver architecture
por: Sá Cunha, António, et al.
Publicado: (2005)

Expression of fibrillin-1 in focal nodular hyperplasia of the liver: a role in microcirculation adaptability
por: Lepreux, Sébastien, et al.
Publicado: (2004)

Over-expression of glutamine synthase in focal nodular hyperplasia (part 1): Early stages in the formation support the hypothesis of a focal hyper-arterialisation with venous (portal and hepatic) and biliary damage
por: Bioulac-Sage, Paulette, et al.
Publicado: (2008)

Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma
por: Poussin, Karine, et al.
Publicado: (2013)

FNH-like nodules: Possible precursor lesions in patients with focal nodular hyperplasia (FNH)
por: Lepreux, Sébastien, et al.
Publicado: (2003)

Association of adenoma and focal nodular hyperplasia: experience of a single French academic center
por: Laurent, Christophe, et al.
Publicado: (2003)

Value and Limits of Routine Histology Alone or Combined with Glutamine Synthetase Immunostaining in the Diagnosis of Hepatocellular Adenoma Subtypes on Surgical Specimens
por: Bioulac-Sage, Paulette, et al.
Publicado: (2013)

Malignant transformation of hepatocellular adenoma
por: Julien, Céline, et al.
Publicado: (2022)

APC germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structures
por: Morcrette, Guillaume, et al.
Publicado: (2019)

Actin Depolymerization in Dedifferentiated Liver Sinusoidal Endothelial Cells Promotes Fenestrae Re‐Formation
por: Di Martino, Julie, et al.
Publicado: (2018)

Pathological Diagnosis of Hepatocellular Cellular Adenoma according to the Clinical Context
por: Bioulac-Sage, Paulette, et al.
Publicado: (2013)

Hepatocellular Adenomas Associated with Hepatic Granulomas: Experience in Five Cases
por: Bieze, Matthanja, et al.
Publicado: (2012)

Spectrum of HNF1A Somatic Mutations in Hepatocellular Adenoma Differs From That in Patients With MODY3 and Suggests Genotoxic Damage
por: Jeannot, Emmanuelle, et al.
Publicado: (2010)

Immunohistochemical study of the phenotypic change of the mesenchymal cells during portal tract maturation in normal and fibrous (ductal plate malformation) fetal liver
por: Villeneuve, Julien, et al.
Publicado: (2009)

Molecular Classification of Hepatocellular Adenomas
por: Nault, Jean Charles, et al.
Publicado: (2013)

Genomics of Viral Hepatitis-Associated Liver Tumors
por: Péneau, Camille, et al.
Publicado: (2021)

Genetics of Hepatocellular Carcinoma: From Tumor to Circulating DNA
por: Campani, Claudia, et al.
Publicado: (2023)

aCNViewer: Comprehensive genome-wide visualization of absolute copy number and copy neutral variations
por: Renault, Victor, et al.
Publicado: (2017)

Mutational signatures: the patterns of somatic mutations hidden in cancer genomes()
por: Alexandrov, Ludmil B, et al.
Publicado: (2014)

The clinical implications of G1-G6 transcriptomic signature and 5-gene score in Korean patients with hepatocellular carcinoma
por: Ahn, Sung-Min, et al.
Publicado: (2018)

Next-generation sequencing identified new oncogenes and tumor suppressor genes in human hepatic tumors
por: Amaddeo, Giuliana, et al.
Publicado: (2012)

Discovering cryptic splice mutations in cancers via a deep neural network framework
por: Teboul, Raphaël, et al.
Publicado: (2023)

Molecular Determinants of Prognosis in Hepatocellular Carcinoma
por: Nault, Jean-Charles
Publicado: (2014)

Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma
por: Ilboudo, Adeodat, et al.
Publicado: (2014)

Transarterial chemoembolization for early stage hepatocellular carcinoma decrease local tumor control and overall survival compared to radiofrequency ablation
por: Hocquelet, Arnaud, et al.
Publicado: (2016)

Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification
por: Balabaud, Charles, et al.
Publicado: (2013)

Polyploidy spectrum: a new marker in HCC classification
por: Bou-Nader, Myriam, et al.
Publicado: (2020)

Functional Annotation: Extracting functional and regulatory order from microarrays
por: Imbeaud, Sandrine, et al.
Publicado: (2005)

Portal hypertension and hepatocellular carcinoma: Navigating uncharted waters
por: Sidali, Sabrina, et al.
Publicado: (2022)

Deciphering Signatures of Mutational Processes Operative in Human Cancer
por: Alexandrov, Ludmil B., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hdjfriid9600pj0uksk70bm78h